PhosImmune
Charlottesville
About PhosImmune
PhosImmune is a clinical-stage biotechnology company developing therapeutic cancer vaccines. PhosImmune controls a library of unique, aberrantly phosphorylated tumor antigens (PTAs) that are directly implicated in metastasis, meeting a pressing need for high quality tumor antigens for use in new and more effective cancer vaccines.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: M&A
- Last round: Series Unknown (Aug 2014)
- Website: phosimmune.com
- Phone: 434-981-4995
Industries & Categories
Biotechnology, Clinical Trials
Canonical: https://fsome.com/organization/phosimmune-2274021 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.